₹52.80
−5.68%NSE close, 16 Nov 2026
−35.01%
Alpa Laboratories is a small cap company, listed on NSE under the symbol ALPA. At ₹52.80 a share, the market values the whole company at ₹111 crore.
In FY26, it reported sales of ₹106 crore and a net profit of ₹15 crore, an operating margin of 3.1%. Over the last three years, sales grew 4.6% a year and net profit grew 5.8% a year.
The market values the company at 46.1 times its profit over the last twelve months and 0.60 times its book value; its return on equity is 1.3% and it has almost no borrowings.
Promoters hold 57.19% of the shares. Foreign institutions hold 0.35%, and domestic institutions, mutual funds among them, 0.07%.
Over the past year the share price has fallen 39.4%, and it is 42.9% below its 52-week high.
₹ crore. Consolidated figures.
Results for the quarter and half year ended September 30, 2026.
A copy Srutinizers report of undefined held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 30, 2026
Appointment of Ms Ms. Diksha Jaswani as Company Secretary of the company w.e.f. September 17, 2026.
Record date for the purpose of Meeting is 22-Sep-2026.
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 27.3 | 23.6 | 21.4 | 24.9 | 26.2 | 39.9 | 19.1 | 26.3 | 29.1 | 31.4 | 23.9 | 31.0 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 24.9 | 20.1 | 20.9 | 21.6 | 25.4 | 39.7 | 18.7 | 28.5 | 27.5 | 27.8 | 27.9 | 33.2 |
| Operating profit | 2.4 | 3.5 | 0.5 | 3.3 | 0.7 | 0.2 | 0.4 | −2.2 | 1.5 | 3.6 | −4.0 | −2.2 |
| Operating margin | 8.9% | 14.9% | 2.5% | 13.3% | 2.8% | 0.5% | 2.2% | -8.5% | 5.2% | 11.5% | -16.5% | -7.2% |
| Other income | 3.5 | 4.0 | 5.2 | 6.9 | 8.8 | 2.5 | 11.9 | 3.1 | 0.9 | −0.2 | 5.8 | 1.2 |
| Interest | 0.0 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 |
| Depreciation | 0.7 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.2 | 0.7 | 0.8 |
| Profit before tax | 5.3 | 6.7 | 5.1 | 9.7 | 8.9 | 2.1 | 11.8 | 0.1 | 1.8 | 3.1 | 1.0 | −1.9 |
| Tax | 0.8 | 3.1 | 0 | 2.0 | 0 | 4.2 | 0 | 0 | −0.2 | 1.7 | 0 | 0 |
| Net profit | 4.5 | 3.6 | 5.1 | 7.7 | 8.9 | −2.1 | 11.8 | 0.1 | 1.9 | 1.4 | 1.0 | −1.9 |
| EPS (₹) | 2.17 | 1.71 | 2.42 | 3.66 | 4.23 | -0.95 | 5.59 | 0.05 | 0.90 | 0.24 | 0.49 | -0.85 |
₹ crore, financial years to March.
| Line | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Sales | 86.0 | 97.6 | 112 | 92.4 | 109 | 112 | 106 |
| Expenses | 82.6 | 89.9 | 102 | 84.8 | 101 | 108 | 103 |
| Operating profit | 3.4 | 7.7 | 10.7 | 7.6 | 8.2 | 4.8 | 3.3 |
| Operating margin | 3.9% | 7.9% | 9.5% | 8.2% | 7.5% | 4.2% | 3.1% |
| Other income | 2.9 | 4.4 | 10.8 | 9.9 | 14.9 | 23.4 | 15.8 |
| Interest | 0.2 | 0.1 | 0.2 | 0.2 | 0.4 | 0.2 | 0.3 |
| Depreciation | 3.2 | 1.2 | 1.7 | 1.3 | 2.0 | 2.2 | 2.1 |
| Profit before tax | 2.9 | 10.8 | 19.6 | 16.0 | 20.8 | 25.7 | 16.7 |
| Tax | 1.1 | 3.5 | 5.5 | 3.3 | 3.9 | 6.2 | 1.7 |
| Net profit | 1.9 | 7.2 | 14.1 | 12.7 | 16.9 | 19.5 | 15.0 |
| EPS (₹) | 0.89 | 3.45 | 6.67 | 5.94 | 8.07 | 9.34 | 6.71 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 2.0 | 7.1 | 10.0 | −3.0 |
| From investing | −15.6 | −1.1 | −11.6 | 1.8 |
| From financing | 5.6 | −5.5 | 2.2 | −1.4 |
| Spent on fixed assets | −2.2 | −11.4 | −4.0 | −0.5 |
| Free cash flow | −0.2 | −4.3 | 6.0 | −3.5 |
Margins, returns, debt, tax and cash.
| Line | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net margin | 2.2% | 7.4% | 12.6% | 13.7% | 15.5% | 17.3% | 14.2% |
| Operating margin | 3.9% | 7.9% | 9.5% | 8.2% | 7.5% | 4.2% | 3.1% |
| Return on equity | – | – | – | 9.4% | 11.1% | 11.4% | 8.1% |
| Return on capital employed | – | – | – | 11.8% | 13.5% | 15.1% | 9.0% |
| Return on assets | – | – | – | 7.6% | 9.2% | 8.8% | 6.2% |
| Debt to equity | – | – | – | 0.02 | 0.03 | 0.00 | 0.01 |
| Interest coverage | 15.60 | 135.80 | 82.50 | 73.60 | 60.40 | 112.60 | 65.20 |
| Debt to assets | – | – | – | 0.01 | 0.03 | 0.00 | 0.01 |
| Current ratio | – | – | – | 4.98 | 5.69 | 4.10 | 4.01 |
| Quick ratio | – | – | – | 4.56 | 5.21 | 3.72 | 3.76 |
| Cash ratio | – | – | – | 0.29 | 0.00 | 0.00 | 0.01 |
| Asset turnover | – | – | – | 0.55 | 0.60 | 0.51 | 0.44 |
| Fixed asset turnover | – | – | – | 13.28 | 9.53 | 5.46 | 5.26 |
| Inventory turnover | – | – | – | – | 5.00 | 4.00 | 5.00 |
| Receivables turnover | – | – | – | 2.00 | 2.60 | 2.40 | 2.60 |
| Gross margin | – | – | – | – | 37.4% | 37.6% | 37.3% |
| Cash from operations to profit | – | – | 14.0% | – | – | 36.0% | 66.0% |
| Effective tax rate | 36.1% | 32.8% | 28.0% | 20.7% | 18.8% | 24.0% | 10.1% |
Appointment of Mrs RADHIKA as Non- Execut of the company w.e.f. September 05, 2026.
The financial results for the period ended Jun 30, 2026.
Clarification board meeting date
The Exchange had sought clarification from Alpa Laboratories Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the…
Cessation of Ms.Jyoti Jain as Non- Executive Independent Director of the company w.e.f. July 21, 2026.
Cessation of Ms Yashoda Patidar as Company Secretary & Compliance Officer of the company w.e.f. July 26, 2026.
The Exchange has sought clarification from Alpa Laboratories Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the…
A copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.